Total Funding
29
Total FundingGrant raised
Growth Score
pts
Heat Score
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
125992
Propagenix is focuses on development and commercialization of products to support applications in translational biomedical research.
Brian A. Pollok: Founder, Board Director, and Principal InvestigatorPast Role: Propagenix, Founder, President, and CEO- Richard Schlegel: Co-Founder and Chair, Scientific Advisory Council
About the Company
Propagenix is a healthcare technology platform developer that aims to provide individualized diagnostics and cell therapies to improve human health. The company's systems are used in advanced therapies in development to differentiate primary epithelial adult stem cells for use in tissue models for drug discovery and toxicology screening,
allowing medical professionals to address the acute shortage of transplantable organs that require mature, functional epithelial tissues such as skin, airways, and kidneys.
Women Founded
